Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused tricyclic compounds for the treatment of inflammatory disorders

Fused tricyclic compounds for the treatment of inflammatory disorders

US Patent 8598158 · Granted Dec 3, 2013

Estimated economic value: $75,696,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopentapyrrole orexin receptor agonists2025
Factor XI activation inhibitors2025
Prevention and treatment of organ injuries2025
Treatment and prevention of nephrotoxin-induced kidney injuries2025
Small molecule inhibitors of KRAS G12C mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
Arginase inhibitors and methods of use2025
Arginase inhibitors and methods of use2025
Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors2024
Opioid receptor ligands and methods of using and making same2024
Therapeutic use of antibodies against ENPP32023